SUMMARY
Research and Development Manufacturing Scientist with successful track
record of pharmaceutical process development, clinical product
manufacturing, process validation and transition to routine commercial
manufacturing. Significant accomplishments include two implant products
successfully manufactured, tested in clinical investigations and approved
by global health authorities. Excellent communication and collaboration
skills enabling successful managed relationships with external vendors and
contractors.
. Manufactured two polyurethane implant products which resulted in
successful clinical trials.
. Increased the delivery rate of one polyurethane implant product
greater than the expected level and ahead of schedule.
. NDA submissions of both the Vantas and Supprelin LA implants were
approved on first cycle review.
. Validation and initial commercial lots for both Vantas and Supprelin
LA implants were successfully completed on schedule.
EDUCATION
M.S. - Pharmacology Graduate School of Basic Medical Sciences, New York
Medical College, Valhalla, NY
B.A. - Biology State University of NY at Purchase, Purchase,
NY
PROFESSIONAL EXPERIENCE
Associate Director, R&D - Endo Pharmaceuticals, Cranbury NJ - 2007 to 2014
(Legacy: Hydro Med Sciences,
Valera Pharmaceuticals, Indevus Pharmaceuticals)
. Collaborated with the R&D group to modify the formulation of the
Risperidone polyurethane implant in order to increase the drug
delivery rate. Delivery rate was increased beyond the 20% expected
level and project completion was two months ahead of schedule.
. Supervised the manufacture of two polyurethane implant products
which resulted in successful clinical trials.
. Co-lead team which planned and designed the construction of the
Clinical Manufacturing suites.
. Authored API cleaning verification protocols for clean rooms and
equipment used in clinical manufacturing. Supervised the execution
of the protocols.
. Developed design specifications for new production equipment and
collaborated with the manufacturers to ensure that the equipment
adhered to the user requirements.
. Wrote the factory and site acceptance tests (FAT and SAT) protocols
for new production equipment. Supervised protocol execution and
summarized successful results in technical reports.
. Collaborated with Facilities and QA Departments in the generation
of equipment change control forms, work instructions and IQ/OQ/PQ
protocols for equipment in the R&D Formulations Department.
. Supervised and trained team of two technicians in the R&D
Formulations Department for the manufacture of feasibility and
clinical drug implants.
. Approved equipment purchases and personnel hiring.
. R&D liaison responsible for the collaboration between the
manufacturing, technical services and QA departments.
. Resolved the technical issues which delayed the evaluation and
qualification of automated equipment required for polyurethane
implant manufacturing resulting in on-time completion of the
qualification.
Associate Director of Technical Services - 2005 to 2007
. Developed, implemented and validate all manufacturing process
improvements.
. Evaluated new manufacturing equipment, materials and processes;
authored proof of principle protocols, design specifications and
IQ/OQ/PQ protocols.
. Collaborated in the validation and set-up of the Steris Finn-Aqua
Sterilizer for use in the commercial manufacture of implants when
external contractor terminated service; post approval supplement
approved without comment.
. Led the investigations and wrote CAPAs related to drug implant
manufacturing deviations.
Manufacturing Technology Manager - 2004 to 2005
. Led manufacturing sub-team for the NDA submissions of Vantas and
Supprelin LA implants; both were approved on first cycle review.
. Contributed to the regulatory submissions for Vantas in Canada
and several European countries where it was also approved.
. Process validation and subsequent initial commercial lots for
both Vantas and Supprelin LA implants were successfully
completed on schedule.
. Directed the scale-up of the Histrelin implant from clinical lots
to commercial batch sizes (50% increase) and authored the
associated master formulas and work instructions.
Manufacturing Manager - 2003 to 2004
. Managed the Manufacturing Department which included 1 supervisor
and 6 operators.
. Supervised the production of the Vantas and Supprelin LA
clinical trial lots.
. Maintained clinical raw material inventory.
. Trained the manufacturing personnel in the production of Vantas
and Supprelin LA implants.
Laboratory Manager - 1999 to 2003
. Supervised three technicians in the QC and R&D Laboratories.
. Verified all raw material, in-process and final product testing
results.
. Reviewed all lab notebooks, test methods and protocols for
compliance with cGMP's and method validation (HPLC, GC, FTIR and
UV) packages for compliance with ICH guidelines.
. Evaluated all new API feasibility data.
. Developed, implemented and maintained laboratory test methods,
specifications and SOPs.
Senior Quality Control Auditor - ICM Laboratories, Inc., Randolph, NJ -
1998 to 1999
. Responsible for the final review of all data package generated in
the Environmental Laboratory including NY ASP, NJ CLP and NJDEP
reduced and regulatory deliverables.
Revised SOP's and maintained the laboratory's certification.
TRAINING/WORKSHOPS
Microsoft Excel - Beyond the Basics-Fred Pryor Seminars - 3/2014
Computer System Validation in FDA-regulated Industries Seminar - Validation
Associates, Inc. - 03/2012
Training for Piccola PLC Tablet Press 460 and Director Software - Specialty
Measurements Inc. - 02/2012
Hands-On Tablet Technology - University of Tennessee Health Science Center
- 06/2011
Workshop on Cleaning and Sanitizing Clean rooms and Controlled Environments
- IEST - 5/2010
Current Good Manufacturing Practices - Endo Pharmaceuticals - 04/2009
Sterilization Procedures: Technology, Equipment and Validation - CfPIE -
03/2009
Technical Writing in the Pharmaceutical and Allied Industries - CfPA -
01/2009
Implementing Best Practices for Cleaning Validation - PTI International -
05/2008
Implementing Key Requirements for Process Validation - PTI International -
04/2008